August 7, 2015 : Episode 1

Video

Lenvatinib Breakthrough Designation, New Drug Applications for NSCLC, STS, and More

Related Videos
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Brian I. Rini, MD, FASCO
A panel of 4 experts on lung cancer
A panel of 4 experts on lung cancer
5 KOLs are featured in this peer exchange
5 KOLs are featured in this peer exchange
Marc Machaalani, MD
Razane El Hajj Chehade, MD
Antonio Cigliola, MD
Related Content
Lisa Conte
July 23rd 2024

Crofelemer Misses Diarrhea End Point in Patients With Solid Tumors Receiving Targeted Therapy

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

Razane El Hajj Chehade, MD
July 18th 2024

Clear Cell Histology Associated With Increased Risk of irAEs in Metastatic RCC

Hari B. Keshava, MD
October 23rd 2023

Keshava Emphasizes the Importance of Lung Nodule Programs for Early Lung Cancer Detection

RCC | Image Credit: © SciePro - stock.adobe.com
July 17th 2024

NCCN Updates Kidney Cancer Clinical Practice Guidelines

FDA
July 16th 2024

FDA Grants Fast Track Designation to ABD-147 for ES-SCLC